Exact Mass: 402.0062
Exact Mass Matches: 402.0062
Found 89 metabolites which its exact mass value is equals to given mass value 402.0062,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
dTDP
Is an intermediate in the Thymidylate kinase (EC 2.7.4.9; ATP:dTMP phosphotransferase) catalyzes the phosphorylation of dTMP (to form dTDP) in the dTTP synthesis pathway for DNA synthesis. (OMIM 188345 ) [HMDB]. dTDP is found in many foods, some of which are bog bilberry, poppy, garden tomato, and chanterelle. Is an intermediate in the Thymidylate kinase (EC 2.7.4.9; ATP:dTMP phosphotransferase) catalyzes the phosphorylation of dTMP (to form dTDP) in the dTTP synthesis pathway for DNA synthesis. (OMIM 188345 ) Acquisition and generation of the data is financially supported in part by CREST/JST. D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents
N-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide
dichlorodihydrofluorescein
Dichlorofluorescin
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
Roflumilast
R - Respiratory system > R03 - Drugs for obstructive airway diseases C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
7,7a-Dichloro-3',6'-dihydroxyspiro[7H-2-benzofuran-3,9'-xanthene]-1-one
(7E,13E,15Z)-14,16-dibromohexadeca-7,13,15-trien-5-ynoic acid|14,16-Dibromo-7,13,15-hexadecatrien-5-ynoic acid-(7E,15Z)-form
Roflumilast
R - Respiratory system > R03 - Drugs for obstructive airway diseases C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
14,16-dibromo-7E,13E,15Z-hexadecatrien-5-ynoic acid
5-(5-amino-2-chloroanilino)-2-(2,4,6-trichlorophenyl)-1H-pyrazol-3-one
1-TERT-BUTYL 3-METHYL 5-IODO-1H-INDAZOLE-1,3-DICARBOXYLATE
Bis(1-propyl-3-methylcyclopentadienyl)zirconium dichloride
bis(tert-butylcyclopentadienyl)zirconium dichloride
Silver,(6,6,7,7,8,8,8-heptafluoro-2,2-dimethyl-3,5-octanedionato-kO3,kO5)-
1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-hexadecafluorooctane
1-(4-chlorophenyl)sulfanyl-4-[ethoxy(propylsulfanyl)phosphoryl]oxybenzene
disodium,5-[2-(1,4,6,9-tetraoxa-5-silanuidaspiro[4.4]nonan-5-yloxy)ethoxy]-1,4,6,9-tetraoxa-5-silanuidaspiro[4.4]nonane
1-O-tert-butyl 5-O-methyl 3-iodoindazole-1,5-dicarboxylate
S-(Trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate
methyl 8-iodo-4,5,7-trimethoxynaphthalene-2-carboxylate
1-ETHYL-3-METHYLPYRIDINIUM BIS(TRIFLUOROMETHANESULFONYL)IMIDE
2,3-BIS(3-CHLOROPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE
2,3-BIS(4-CHLOROPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE
4-(Cyclopropylmethoxy)-3-(difluoromethoxy) Roflumilast
1,2,3,5-tetramethylcyclopenta-1,3-diene,zirconium(4+),dichloride
1-(2,4,6-Trichlorophenyl)-3-(5-amino-2-chloroanilino)-5-pyrazolone
Parconazole hydrochloride
C254 - Anti-Infective Agent > C514 - Antifungal Agent
2,7-Dichlorodihydrofluorescein
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
4-[(3-Chlorophenyl)hydrazinylidene]-3-(4-nitrophenyl)-5-oxo-1-pyrazolecarbothioamide
5-(2,4-dichlorophenyl)-4,6-dioxo-3a,6a-dihydro-2H-pyrrolo[3,4-d]isoxazole-3,3-dicarboxylic acid dimethyl ester
N-((E)-{4-[(2-chloro-1,3-thiazol-5-yl)methoxy]-3-methoxyphenyl}methylidene)isonicotinohydrazide
2-[[1-(4-Methoxy-2-nitrophenyl)-2,5-dioxo-3-pyrrolidinyl]thio]benzoic acid
(2s)-N-[(3s)-1-(2-Amino-2-Oxoethyl)-2-Oxo-1,2,3,4-Tetrahydroquinolin-3-Yl]-2-Chloro-2h-Thieno[2,3-B]pyrrole-5-Carboxamide
[[(2R,3S,4R,5R)-5-(3,5-dioxo-1,2,4-triazin-2-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate
(2R,3R,4S)-2-[(2S,3S,4S,5R)-5,6-dihydroxy-2-methyl-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
4-Fluorobenzoic acid 4-[[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}but-2-yn-1-yl 4-fluorobenzoate
1-[(2-chlorophenyl)methyl]-3-methyl-N-(4-methyl-2-thiazolyl)-5-thieno[2,3-c]pyrazolecarboxamide
1-[2,4-Dichloro-5-(methylsulfonylamino)phenyl]-3-(hydroxymethyl)-4-(difluoromethyl)-1H-1,2,4-triazol-5(4H)-one
[4,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] hydrogen sulate
4-Acetyl-1-(5-bromopyridin-2-yl)-5-(4-methoxyphenyl)pyrrolidine-2,3-dione
3,7-dihydroxy-2-(3-sulooxyphenyl)-3,4-dihydro-2H-chromene-5-sulinic acid
[3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl] hydrogen sulate
18-Bromo-4,10-diaza-15-azoniahexacyclo[14.3.1.15,9.01,6.07,15.08,12]henicosa-5,7(15),8(12),9(21),10,18-hexaene-17,20,21-triol
Thymidine-5-diphosphate
A thymidine phosphate having a diphosphate group at the 5-position. D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents
gluconapoleiferin(1-)
A glucosinolate that is glucobrassicanapin which has been hydroxylated at the 3-position of the hex-5-enimidoyl chain.
PEPA
PEPA is an allosteric modulator of AMPA receptors; binds to the GluA2o and GluA3o LBDs and can be utilized as an indicator of AMPA receptor heterogeneity. IC50 value: Target: AMPAR modulator in vitro: PEPA dose-dependently potentiated AMPA-induced increase of [Ca2+]i. In 90\% (72 out of 80) of the cells in which cyclothiazide acts, PEPA potentiated the increased [Ca2+]i induced by AMPA with pronounced cell-to-cell variation in rat hippocampal cultures [1]. PEPA bound to the binding domains of the GluA2 and GluA3 flop isoforms of AMPA receptors [2]. coapplication of AMPA with PEPA protected hippocampal CA1 neurons from brain ischemia-induced death. Coapplication of AMPA with PEPA could prevent downregulated expression of GluR2 subunit caused by ischemia and increase BDNF expression via Lyn-ERK1/2-CREB signaling [4]. in vivo: PEPA (3, 10, 30mg/kg body weight) or vehicle was intraperitoneally administered into stressed mice once before the first extinction session. The significant decrease of the freezing response in the extinction sessions was only seen in the 30mg/kg PEPA-administered stressed mice, compared with vehicle-administered stressed mice [3].
Pomaglumetad methionil (hydrochloride)
Pomaglumetad methionil hydrochloride (LY2140023 hydrochloride) is an orally active, methionine prodrug of the selective mGlu2/3 receptor agonist LY404039. Pomaglumetad methionil hydrochloride has the potential for schizophrenia research[1][2].
